Cargando…

Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities

Dravet Syndrome (DS) is a developmental epileptic encephalopathy characterized by drug-resistant seizures and other clinical features, including intellectual disability and behavioral, sleep, and gait problems. The pathogenesis is strongly connected to voltage-gated sodium channel dysfunction. The c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Chao, Pielas, Mikolaj, Jiao, Fuyong, Mei, Daoqi, Wang, Xiaona, Kotulska, Katarzyna, Jozwiak, Sergiusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094968/ https://www.ncbi.nlm.nih.gov/pubmed/37048615 http://dx.doi.org/10.3390/jcm12072532

Ejemplares similares

Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex—Current Views on Their Pathogenesis and Management
por: Gao, Chao, et al.
Publicado: (2023)

Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age
por: Śmiałek, Dominika, et al.
Publicado: (2023)

Safety of Sirolimus in Patients with Tuberous Sclerosis Complex under Two Years of Age—A Bicenter Retrospective Study
por: Śmiałek, Dominika, et al.
Publicado: (2023)

Epilepsy and Language Development in 8–36-Month-Old Toddlers with Tuberous Sclerosis Complex
por: Foryś-Basiejko, Małgorzata, et al.
Publicado: (2022)

Dravet Syndrome as an Example of Precision Medicine in Epilepsy
por: Sullivan, Joseph, et al.
Publicado: (2022)

Cannabidiol for epilepsy (Lennox-Gastaut syndrome, Dravet syndrome)
Publicado: (2020)

Maintenance Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis – Final Results From the EMINENTS Study
por: Bobeff, Katarzyna, et al.
Publicado: (2021)

Clinical and molecular analysis of epilepsy-related genes in patients with Dravet syndrome
por: Jiang, TieJia, et al.
Publicado: (2018)

Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy
por: Nabbout, Rima, et al.
Publicado: (2013)

Risk Factors Associated with Refractory Epilepsy in Patients with Tuberous Sclerosis Complex: A Systematic Review
por: Miszewska, Dominika, et al.
Publicado: (2021)

Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex
por: Kotulska, Katarzyna, et al.
Publicado: (2014)

New Insights into Red Blood Cell Microcytosis upon mTOR Inhibitor Administration
por: Jakubowska, Justyna, et al.
Publicado: (2021)

Newborn screening and gene therapy in SMA: Challenges related to vaccinations
por: Kotulska, Katarzyna, et al.
Publicado: (2022)

Dravet syndrome
por: Incorpora, Gemma
Publicado: (2009)

Clinical and genetic analysis of benign familial infantile epilepsy caused by PRRT2 gene variant
por: Gu, Yu, et al.
Publicado: (2023)

Antiepileptic Effect and Safety Profile of Rapamycin in Pediatric Patients With Tuberous Sclerosis Complex
por: Sadowski, Krzysztof, et al.
Publicado: (2022)

Abnormal serum microRNA profiles in tuberous sclerosis are normalized during treatment with everolimus: possible clinical implications
por: Trelinska, Joanna, et al.
Publicado: (2016)

Electroencephalography characteristics related to risk of sudden unexpected death in epilepsy in patients with Dravet syndrome
por: Kim, Jeong-Youn, et al.
Publicado: (2023)

Vaccinations and Dravet Syndrome
por: Korff, Christian M.
Publicado: (2015)

Phenotypes of Dravet Syndrome
por: Garcia-Sosa, Rebecca, et al.
Publicado: (2016)

Dravet Syndrome: An Overview
por: Anwar, Arsalan, et al.
Publicado: (2019)

Stiripentol for Dravet syndrome
Publicado: (2020)

SCN1A Genetic Test for Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy and its Clinical Subtypes) for use in the Diagnosis, Prognosis, Treatment and Management of Dravet Syndrome
por: Stenhouse, Susan A.R., et al.
Publicado: (2013)

The Role of Focal Epilepsy Features in Defining SCN1A Mutation-positive Dravet Syndrome as Generalized and Focal Epilepsy
por: Ko, Young Jun, et al.
Publicado: (2021)

Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures?
por: Słowińska, Monika, et al.
Publicado: (2018)

Severe myoclonic epilepsy of infancy (Dravet syndrome): Clinical and genetic features of nine Turkish patients
por: Özmen, Meral, et al.
Publicado: (2011)

Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex
por: Silvinato, Antônio, et al.
Publicado: (2022)

Sleep slow-wave oscillations trigger seizures in a genetic epilepsy model of Dravet syndrome
por: Catron, Mackenzie A, et al.
Publicado: (2022)

mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

Crouch Gait in Dravet Syndrome
por: Black, Laura, et al.
Publicado: (2016)

Anesthetic considerations in Dravet syndrome
por: Macdonald‐Laurs, Emma, et al.
Publicado: (2022)

Open the Window for the Cure of Dravet
por: Gu, Bin
Publicado: (2022)

Ataluren for drug‐resistant epilepsy in nonsense variant‐mediated Dravet syndrome and CDKL5 deficiency disorder
por: Devinsky, Orrin, et al.
Publicado: (2021)

MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
por: Jain, Aditi, et al.
Publicado: (2021)

Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex?
por: Moavero, Romina, et al.
Publicado: (2020)

Do All Roads Lead to Rome? Genes Causing Dravet Syndrome and Dravet Syndrome-Like Phenotypes
por: Ding, Jiangwei, et al.
Publicado: (2022)

Editorial: Viral vector-based gene therapy in neurological disease: The future is now
por: Smith, Jared B., et al.
Publicado: (2023)

Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation
por: Ricobaraza, Ana, et al.
Publicado: (2019)

Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program
por: Pernici, Chelsea D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1vusrqr6a6cdujpbr4g6ii3nm0